Clinical trial

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

NCT01218529

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE2

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2014-12-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Brain Metastasesunresolved

Lung Tumorsunresolved

Breast Tumorsunresolved

Interventions

LapatinibDRUG · verified · RxNorm: lapatinib

Sponsors & collaborators

Hellenic Cooperative Oncology Grouplead sponsor

Mapped research locations

AthensGreece8 ThessalonikiGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01218529 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.